Cuprina Holdings is trading 12.1% down at $1.81, with no clear company-specific catalyst identified for October 13. - The reported Singapore clinic acquisition was announced October 2, not overnight. - Cuprina is a biomedical company, not a crypto-related business; modest BTC and ETH gains do not explain the decline. - The prior session’s 21.89% rise may provide context, but available information does not establish a cause.